journal article·2021-10

Recent Advances for Improving Functionality, Biocompatibility, and Longevity of Implantable Medical Devices and Deliverable Drug Delivery Systems

Neta Kutner, Konda Reddy Kunduru, Luna Rizik, Shady Farah

Advanced Functional Materials· Volume 31· Issue 44
Publisher page

Abstract

Abstract The great majority of medical devices elicit foreign body response (FBR) postimplantation. FBR is a major hurdle to develop a successful device for impaired organs, leading to failure of devices/treatments. In recent times, several advantageous technologies have been developed based on either surface modifications or localized drug delivery systems (DDSs) in order to overcome the FBR limitation, which enhanced the success of implantable medical devices. The recent advances for improving the functionality, biocompatibility, and longevity of implantable medical devices and deliverable DDSs are discussed here. It is believed that these advances will further guarantee the improvement of existing implants and deliverable entities while enabling the development of new therapy technologies. Such technologies are anticipated to be long‐term patient‐friendly and thus lead to a higher quality of life.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Laboratory for Advanced Functional/Medicinal Polymers & Smart Drug Delivery Technologies The Wolfson Faculty of Chemical Engineering Technion‐Israel Institute of Technology Haifa 3200003 Israel

The Russell Berrie Nanotechnology Institute Technion‐Israel Institute of Technology Haifa 3200003 Israel

References (100+)

Show source-provided references
1. 10.1021/cr200091610.1021/cr2000916 ↗
2. 10.1038/s41578-019-0150-z10.1038/s41578-019-0150-z ↗
3. 10.1007/978-1-4614-9434-8_210.1007/978-1-4614-9434-8_2 ↗
4. 10.1126/science.305530010.1126/science.3055300 ↗
5. 10.1016/j.jconrel.2012.02.01010.1016/j.jconrel.2012.02.010 ↗
6. 10.1126/scitranslmed.300327610.1126/scitranslmed.3003276 ↗
7. 10.1016/B978-0-12-800196-7.00001-310.1016/B978-0-12-800196-7.00001-3 ↗
8. 10.1007/978-3-319-45433-7_110.1007/978-3-319-45433-7_1 ↗
9. 10.1016/j.addr.2019.08.01010.1016/j.addr.2019.08.010 ↗
10. 10.1055/s-0033-136419910.1055/s-0033-1364199 ↗
11. 10.1089/dia.2017.032110.1089/dia.2017.0321 ↗
12. O'Malley JT N. J. J. · Otol. Neurotol. · 2017 · 176 · 100
13. 10.1002/lio2.32910.1002/lio2.329 ↗
14. 10.3389/fnins.2017.0049710.3389/fnins.2017.00497 ↗
15. 10.1016/j.clinph.2010.01.00110.1016/j.clinph.2010.01.001 ↗
16. 10.1088/1741-2560/4/4/00710.1088/1741-2560/4/4/007 ↗
17. 10.1038/nmat486610.1038/nmat4866 ↗
18. 10.1513/pats.200507-073JS10.1513/pats.200507-073JS ↗
19. Saltzman W. M. · 2001 · 310.1093/oso/9780195085891.001.0001 ↗
20. 10.1038/s41578-019-0156-610.1038/s41578-019-0156-6 ↗
21. 10.2165/00003088-198409010-0000110.2165/00003088-198409010-00001 ↗
22. 10.1038/s41565-020-0759-510.1038/s41565-020-0759-5 ↗
23. 10.1038/nmat261410.1038/nmat2614 ↗
24. 10.1002/adfm.20200502910.1002/adfm.202005029 ↗
25. 10.1126/science.109583310.1126/science.1095833 ↗
26. 10.1038/natrevmats.2016.7510.1038/natrevmats.2016.75 ↗
27. 10.1039/C6PY01872F10.1039/C6PY01872F ↗
28. 10.1016/j.jcis.2018.10.05610.1016/j.jcis.2018.10.056 ↗
29. 10.1021/nn405878710.1021/nn4058787 ↗
30. 10.1021/acs.cgd.8b0064610.1021/acs.cgd.8b00646 ↗
31. 10.1021/acsami.6b1049110.1021/acsami.6b10491 ↗
32. 10.1016/j.ultsonch.2013.11.02210.1016/j.ultsonch.2013.11.022 ↗
33. 10.1038/s41427-018-0100-z10.1038/s41427-018-0100-z ↗
34. 10.1016/j.ijbiomac.2020.09.03110.1016/j.ijbiomac.2020.09.031 ↗
35. 10.1021/acs.bioconjchem.5b0024210.1021/acs.bioconjchem.5b00242 ↗
36. 10.1007/978-1-4939-3121-7_1810.1007/978-1-4939-3121-7_18 ↗
37. 10.1039/c2jm30501a10.1039/c2jm30501a ↗
38. 10.1007/s10787-009-0016-x10.1007/s10787-009-0016-x ↗
39. 10.1084/jem.140.4.106810.1084/jem.140.4.1068 ↗
40. 10.1016/j.actbio.2017.06.00110.1016/j.actbio.2017.06.001 ↗
41. 10.14218/JCTH.2017.0003110.14218/JCTH.2017.00031 ↗
42. 10.1016/j.addr.2018.10.00210.1016/j.addr.2018.10.002 ↗
43. 10.1002/adfm.20150526010.1002/adfm.201505260 ↗
44. 10.1038/s41428-020-0352-710.1038/s41428-020-0352-7 ↗
45. 10.1039/C7CC00041C10.1039/C7CC00041C ↗
46. 10.1021/acsami.8b2037210.1021/acsami.8b20372 ↗
47. 10.1016/S0165-5728(00)00297-610.1016/S0165-5728(00)00297-6 ↗
48. 10.1586/14779072.2.5.65310.1586/14779072.2.5.653 ↗
49. 10.1038/nnano.2015.31110.1038/nnano.2015.311 ↗
50. 10.1038/s41578-020-0230-010.1038/s41578-020-0230-0 ↗
51. 10.1002/adma.20120078510.1002/adma.201200785 ↗
52. 10.3389/fmech.2017.0000710.3389/fmech.2017.00007 ↗
53. 10.1186/s40580-019-0191-410.1186/s40580-019-0191-4 ↗
54. 10.1088/0964-1726/25/2/02700110.1088/0964-1726/25/2/027001 ↗
55. 10.1002/adma.20130409810.1002/adma.201304098 ↗
56. 10.1021/am508621s10.1021/am508621s ↗
57. 10.1016/j.biomaterials.2016.10.01610.1016/j.biomaterials.2016.10.016 ↗
58. 10.1016/j.colsurfb.2019.04.05010.1016/j.colsurfb.2019.04.050 ↗
59. 10.1038/s41563-019-0377-510.1038/s41563-019-0377-5 ↗
60. 10.1016/j.addr.2019.06.00610.1016/j.addr.2019.06.006 ↗
61. 10.1016/j.jconrel.2012.03.01310.1016/j.jconrel.2012.03.013 ↗
62. 10.1016/j.jbiotec.2004.06.00710.1016/j.jbiotec.2004.06.007 ↗
63. 10.1016/j.ijpharm.2013.01.05310.1016/j.ijpharm.2013.01.053 ↗
64. Aronson J. K. · 2016
65. 10.1016/S0959-8049(01)00171-X10.1016/S0959-8049(01)00171-X ↗
66. 10.1016/j.jconrel.2013.02.01210.1016/j.jconrel.2013.02.012 ↗
67. 10.1038/s41569-019-0234-x10.1038/s41569-019-0234-x ↗
68. 10.1016/j.ijpharm.2013.01.05310.1016/j.ijpharm.2013.01.053 ↗
69. Kamińska M. · Acta Bioeng. Biomech. · 2009 · 11 · 19
70. 10.1016/j.snb.2011.08.07310.1016/j.snb.2011.08.073 ↗
71. 10.1016/j.biomaterials.2010.05.05010.1016/j.biomaterials.2010.05.050 ↗
72. 10.1016/j.jconrel.2018.09.00110.1016/j.jconrel.2018.09.001 ↗
73. 10.1016/j.drudis.2016.02.00110.1016/j.drudis.2016.02.001 ↗
74. The Office of Pharmaceutical Quality in the Center for Drug Evaluation and Administration · 2018 · 1
75. 10.1038/srep3839510.1038/srep38395 ↗
76. 10.1038/s41598-017-17765-510.1038/s41598-017-17765-5 ↗
77. D. V.Andreeva inAdvances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents (Eds:M.Rawat Singh J. R.Kanwar D.Singh N. S.Chauhan) Academic Press2020 pp.183–209.10.1016/B978-0-12-819666-3.00006-7 ↗
78. 10.1016/j.ijbiomac.2020.02.14010.1016/j.ijbiomac.2020.02.140 ↗
79. 10.1016/j.apsusc.2020.14680610.1016/j.apsusc.2020.146806 ↗
80. 10.1038/s41467-019-13440-710.1038/s41467-019-13440-7 ↗
81. 10.1002/adfm.20180811610.1002/adfm.201808116 ↗
82. Ge Z. · Small · 2020 · 16 · 6
83. 10.1038/444959a10.1038/444959a ↗
84. 10.1002/marc.20190043010.1002/marc.201900430 ↗
85. 10.1016/B978-0-323-44353-1.00005-110.1016/B978-0-323-44353-1.00005-1 ↗
86. 10.3390/ma1010111510.3390/ma10101115 ↗
87. 10.1016/j.colsurfb.2014.08.00910.1016/j.colsurfb.2014.08.009 ↗
88. 10.1002/masy.1996101015010.1002/masy.19961010150 ↗
89. 10.1021/la060276610.1021/la0602766 ↗
90. 10.1021/la050386x10.1021/la050386x ↗
91. 10.1016/j.bios.2006.04.02110.1016/j.bios.2006.04.021 ↗
92. 10.1016/S0142-9612(01)00334-910.1016/S0142-9612(01)00334-9 ↗
93. 10.1002/anie.20180861510.1002/anie.201808615 ↗
94. 10.1517/17425247.2012.72096910.1517/17425247.2012.720969 ↗
95. 10.1002/wnan.133910.1002/wnan.1339 ↗
96. 10.1016/j.drudis.2014.08.01510.1016/j.drudis.2014.08.015 ↗
97. 10.1002/anie.20171006810.1002/anie.201710068 ↗
98. 10.1002/adma.20090140710.1002/adma.200901407 ↗
99. 10.1039/D0BM00986E10.1039/D0BM00986E ↗
100. 10.1002/anie.20130406010.1002/anie.201304060 ↗